Loading clinical trials...
Loading clinical trials...
A Phase 1, Open-Label Study Evaluating the Pharmacokinetics, Absorption, Safety and Tolerability With Maximal Use of SKX-16 (Luliconazole 10% Solution) in Subjects With Moderate to Severe Distal Subungual Onychomycosis
Conditions
Interventions
SKX-16 (Luliconazole 10% Solution)
Locations
1
United States
J&S Studies, Inc.
College Station, Texas, United States
Start Date
September 13, 2021
Primary Completion Date
December 10, 2022
Completion Date
February 22, 2023
Last Updated
June 14, 2022
Lead Sponsor
SATO Pharmaceutical Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions